$USPH News

Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $98

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy (NYSE:USPH) Misses on EPS, Reaffirms Full-Year Guidance

US Physical Therapy Q2 Adj. EPS $0.75 Misses $0.84 Estimate, Sales $214.059M Beat $211.307M Estimate

Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH)

How U.S. Physical Therapy’s (USPH) Clinic Acquisition Supports Its Outpatient Care Roll-Up Strategy

U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice

U.S. Physical Therapy Acquires Majority Stake In Twelve-Clinic Physical Therapy Practice; Financial Terms Undisclosed

Citizens Reiterates Market Outperform on US Physical Therapy, Maintains $98 Price Target

U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)

3 Reasons USPH is Risky and 1 Stock to Buy Instead

Do These 3 Checks Before Buying U.S. Physical Therapy, Inc. (NYSE:USPH) For Its Upcoming Dividend

U.S. Physical Therapy’s Q1 Earnings Call: Our Top 5 Analyst Questions

U.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know

U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference

Barrington Research Maintains Outperform on US Physical Therapy, Lowers Price Target to $90

U.S. Physical Therapy, Inc. 2026 Q1 - Results - Earnings Call Presentation

U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript

Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98